Abstract
Hindering premature vesicular fusion is key to build up a molecularly primed ready releasable pool. Complexin-II (CpxII), a 16 KD cytosolic protein, inhibits non-synchronous vesicle fusion at release sites, and by that accumulates a ready releasable pool of primed vesicles that are released in synchrony upon immediate elevation of intracellular calcium. Functionally, CpxII is equipped with four independent yet synergetic domains. A central helix mediates the CpxII-SNARE (N-ethylmaleimide-sensitive factor (NSF) attachment protein receptors) complex interaction, while an accessory helix is important for the stability of the central helix and for reducing premature fusion. The upstream N-terminal domain facilitates exocytosis, whereas the downstream C-terminal domain (CTD) inhibits premature fusion of vesicles. The molecular mechanisms how the CTD blocks asynchronous release are still unclear. With the help of high resolution membrane capacitance measurements coupled with calcium imaging, carbon fiber amperometry, and biochemical assays, we show that infusion of CpxII far CTD -derived peptide into mouse chromaffin cells is able to boost the synchronous release by reducing the premature vesicle fusion. A similar phenotype is also observed by over-expressing the full length WT protein. Using in vitro binding assays, we show that the CTD interacts with SNARE proteins. Moreover, we found that the CTD peptide lowers the rate of SDS resistant SNARE complex formation. We also show that the CTD shares a high degree of similarity to the SNARE protein SNAP25-SN1 domain. Furthermore chimeras of CpxII:SNAP25-SN1 fully restore CpxII function, and even “superclamp” tonic secretion. Collectively, these results provide evidence for a clamping mechanism in which the CTD of CpxII prevents the spontaneous assembly of SNARE complexes, enabling the build-up of a ready releasable pool for synchronised Ca2+-triggered exocytosis.
Highlights
SNAP25, the average FRET efficiency increases to $38%
With the help of high resolution membrane capacitance measurements coupled with calcium imaging, carbon fiber amperometry, and biochemical assays, we show that infusion of CpxII far C-terminal domain (CTD) -derived peptide into mouse chromaffin cells is able to boost the synchronous release by reducing the premature vesicle fusion
We show that the CTD shares a high degree of similarity to the SNARE protein SNAP25-SN1 domain
Summary
SNAP25, the average FRET efficiency increases to $38%. Combining electrochemical imaging of fusion events with TIRF-FRET imaging, we detected a SNAP25 conformational change preceding fusion pore opening in SCORE2 overexpressing SNAP25À/À cells, confined to a $0.1 mm2 area surrounding the fusion site. With the help of high resolution membrane capacitance measurements coupled with calcium imaging, carbon fiber amperometry, and biochemical assays, we show that infusion of CpxII far CTD -derived peptide into mouse chromaffin cells is able to boost the synchronous release by reducing the premature vesicle fusion. These results provide evidence for a clamping mechanism in which the CTD of CpxII prevents the spontaneous assembly of SNARE complexes, enabling the build-up of a ready releasable pool for synchronised Ca2þ-triggered exocytosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.